STUDY OF ACUTE TOXICITY OF A NEW VETERINARY DRUG FOR INTTRAMMARY INTRODUCTION

Zhanna Polova

Abstract


Preclinical studies of veterinary medicinal products are important and compulsory studies in the development of new dosage forms. The aim of preclinical research is to determine the toxic effect and therapeutic efficacy of the test substance-the future dosage form, its effect on the body's basic systems, as well as the identification of possible side effects.

This work is part of the research on the development of the composition and technology of the veterinary drug - a solution for intramammary application, conventionally called "Argocide", intended for the treatment of mastitis in cattle.

A study of the acute toxicity of the intramammary veterinary drug was carried out in experiments on white rats of both sexes, according to the requirements for potential medicines. The establishment of the value of the average lethal dose (LD50) of the veterinary drug "Argocide" with intramuscular single administration to white mature rats is impossible due to the absence of animal death even when the drug is administered at doses exceeding 5.0 ml/kg. This experiment allows the veterinary preparation "Argocide" to be classified as practically non-toxic compounds (V class).

The analysis of the results of the conducted studies indicates the relative harmlessness of the potential drug for veterinary medicine and allows us to foresee that the "Argocide" preparation can be classified as low-risk substances, which justifies the expediency of its further study and introduction into practice.


Keywords


preclinical studies; acute toxicity; intramammary veterinary drug; "Argocid"

Full Text:

PDF

References


Kotsiumbas, I. Ya., Malyk, O. H., Patereha, I. P. et. al.; Kotsiumbas, I. Ya. (Ed.) (2006). Doklinichni doslidzhennia veterynarnykh likarskykh zasobiv. Lviv: Triada plius, 360.

Kovalenko, V. M., Stefanov, O. V., Maksymov, Yu. M., Trakhtenberh, I. M.; Stefanov, O. V. (Ed.) (2001). Eksperymentalne vyvchennia toksychnoi dii potentsiinykh likarskykh zasobiv. Doklinichni doslidzhennia likarskykh zasobiv. Kyiv: Avitsena, 74–97.

Pro zatverdzhennia Poriadku provedennia doklinichnoho vyvchennia likarskykh zasobiv ta ekspertyzy materialiv doklinichnoho vyvchennia likarskykh zasobiv. «Eksperymentalne vyvchennia toksychnoi dii potentsiinykh likarskykh zasobiv» (2009). Ministerstvo Okhorony Zdorovia Ukrainy, No. 944. Available at: http://zakon2.rada.gov.ua/laws/show/z0053-10

Research Quality Association. Good Laboratory Practice. Available at: https://www.therqa.com/good-practices/good-laboratory-practice/regulations-guidelines/

Polova, Z., Almakayeva, L., Nehoda, T. (2017). Development of the composition of intramammary combined preparation based on silver citrate for veterinary. Сzech and slovak pharmacy, 66 (5), 227–233.

Polova, Zh. M., Sakhanda, I. V., Dolaichuk, O. P. (2016). Vyvchennia toksykolohichnykh vlastyvostei tsytratu sribla yak aktyvnoho farmatsevtychnoho inhrediienta. Zbirnyk naukovykh prats spivrobitnykiv NMAPO imeni P. L. Shupyka, 24 (4), 290–295.

Almakaieva, L. H., Polova, Zh. M. (2017). Pat. No. 119231 UA. Antymikrobnyi zasib u vyhliadi intramamarnoho rozchynu dlia likuvannia mastytiv u velykoi rohatoi khudoby. MPK (2017.01), A61K 31/00, A61K 31/38. No. u 201707487; declareted: 17.07.2017; published: 11.09.2017, Bul. No. 17.

De Vliegher, S., Fox, L. K., Piepers, S., McDougall, S., Barkema, H. W. (2012). Invited review: Mastitis in dairy heifers: Nature of the disease, potential impact, prevention, and control. Journal of Dairy Science, 95 (3), 1025–1040. doi: 10.3168/jds.2010-4074

De Visscher, A., Piepers, S., Supre, K., Haesebrouck, F., De Vliegher, S. (2015). Short communication: Species group-specific predictors at the cow and quarter level for intramammary infection with coagulase-negative staphylococci in dairy cattle throughout lactation. Journal of Dairy Science, 98 (8), 5448–5453. doi: 10.3168/jds.2014-9088

Oliveira, M., Bexiga, R., Nunes, S. F., Carneiro, C., Cavaco, L. M., Bernardo, F., Vilela, C. L. (2006). Biofilm-forming ability profiling of Staphylococcus aureus and Staphylococcus epidermidis mastitis isolates. Veterinary Microbiology, 118 (1-2), 133–140. doi: 10.1016/j.vetmic.2006.07.008

Murska, S. D. (2014). Protymastytni preparaty dlia intratsysternalnoho vvedennia, zareiestrovani v Ukraini. Naukovo-tekhnichnyi biuleten Instytutu biolohii tvaryn i Derzhavnoho naukovo-doslidnoho kontrolnoho instytutu vetpreparativ ta kormovykh dobavok, 15 (2-3), 360–366.

Kotsiumbas, I. Ya., Horzheiev, V. M. et. al. (2013). Dovidnyk veterynarnykh preparativ. Lviv: TzOV «VF Afisha», 1596.

Polova, Zh. M. (2014). Analiz rynku veterynarnykh likarskykh form dlia zastosuvannia v akusherstvi ta hinekolohii. Farmatsevtychnyi chasopys, 4 (32), 129–134.

Weese, J. S., Giguere, S., Guardabassi, L., Morley, P. S., Papich, M., Ricciuto, D. R., Sykes, J. E. (2015). ACVIM Consensus Statement on Therapeutic Antimicrobial Use in Animals and Antimicrobial Resistance. Journal of Veterinary Internal Medicine, 29 (2), 487–498. doi: 10.1111/jvim.12562

European convention for the protection of vertebrate animals used for experimental and other scientific purposes. Details of Treaty No.123 (1986). Council of European. Strasbourg, 51. Available at: https://www.coe.int/en/web/conventions/full-list/-/conventions/treaty/123

Council Directive 2010/63/EU of 22 September 2010 on the protection of animals used for scientific purposes (2010). Official Journal of the European Communities, L 276, 33–79.

Karkishhenko, N. N., Grachev, S. V. (Eds.) (2010). Rukovodstvo po laboratornym zhivotnym i al'ternativnym modelyam v biomeditsinskikh tekhnologiyakh. Moscow: Profil, 358.

Popova, E. B. (2010). Planirovanie issledovaniy i analiz zavisimostey "doza – effekt" toksichnykh i lekarstvennykh veshhestv. Voenno-meditsinskaya akademiya. Saint Petersburg, 254.

Prozorovskiy, V. B. (2007). Statisticheskaya obrabotka rezul'tatov farmakologicheskikh issledovaniy. Psikhofarmakologiya i biologicheskaya narkologiya, 7 (3-4), 2090–2120.

Rebrova, O. Yu. (2006). Statisticheskiy analiz meditsinskikh dannykh. Primenenie paketa prikladnykh programm STATISTICA. Moscow: Media Sfera, 312.

Bolyakhina, S. A., Nasartdinova, G. F., Donchenko, N. A. et. al. (2014). Issledovanie ostroy i khronicheskoy toksichnosti preparata Argumistin. Sibirskiy vestnik sel'skokhozyaystvennoy nauki, 3, 95–101.

Shkil, N. N., Shkil, N. A., Burmistrov, V. A. (2014). Opredelenie subkhronicheskoy toksichnosti preparata Argovit na laboratornykh zhivotnykh. Veterinariya, 4, 79–84.

Ponomar, N. S., Maklyakov, Yu. S., Sayadova, Z. S. (2014). Izuchenie ostroy toksichnosti novogo preparata ionizirovannogo serebra. Bimeditsina, 3, 101. Available at: https://cyberleninka.ru/article/n/izuchenie-ostroy-toksichnosti-novogo-preparata-ionizirovannogo-serebra

Tiwari, D. K., Jin, T., Behari, J. (2010). Dose-dependent in-vivo toxicity assessment of silver nanoparticle in Wistar rats. Toxicology Mechanisms and Methods, 21 (1), 13–24. doi: 10.3109/15376516.2010.529184

Pryskoka, A. O. (2014). Doslidzhennia hostroi toksychnosti nanochastynok sribla pry vnutrishnovennomu vvedenni. Farmakolohiia ta likarska toksykolohiia, 39, 38–44.

Park, K., Park, E.-J., Chun, I. K., Choi, K., Lee, S. H., Yoon, J., Lee, B. C. (2011). Bioavailability and Toxicokinetics of citrate-coated silver nanoparticles in rats. Archives of Pharmacal Research, 34 (1), 153–158. doi: 10.1007/s12272-011-0118-z

Souza, L. R. R., da Silva, V. S., Franchi, L. P., de Souza, T. A. J. (2018). Toxic and Beneficial Potential of Silver Nanoparticles: The Two Sides of the Same Coin. Cellular and Molecular Toxicology of Nanoparticles. Advances in Experimental Medicine and Biology, 1048, 251–262. doi: 10.1007/978-3-319-72041-8_15




DOI: http://dx.doi.org/10.21303/2504-5679.2018.00600

Refbacks

  • There are currently no refbacks.




Copyright (c) 2018 Zhanna Polova

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

ISSN 2504-5679 (Online), ISSN 2504-5660 (Print)